You have 9 free searches left this month | for more free features.

DNA Damage Repair Deficiency

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

Recruiting
  • Hormone Sensitive Metastatic Prostate Cancer
  • +3 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021

Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

Recruiting
  • Lung Cancer
  • Olaparib+Bevacizumab to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
  • +3 more
Nov 9, 2022

Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers Trial in Clinuvel Investigational Site (Afamelanotide)

Recruiting
  • Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers
  • Clinuvel Investigational Site, United Kingdom
    CLINUVEL Investigational Site
Nov 9, 2022

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • (no location specified)
Jan 14, 2023

Metastatic Pancreatic Cancer Trial in Barcelona, La Coruña, Santander (olaparib+durvalumab)

Recruiting
  • Metastatic Pancreatic Cancer
  • Barcelona, Spain
  • +2 more
Dec 29, 2022

Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

Not yet recruiting
  • Advanced Breast Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 12, 2022

Ultraviolet Rays; Injury, DNA Adduct Formation, DNA Damage, Radiation Induced Trial in Copenhagen NV (Ultraviolet radiation)

Active, not recruiting
  • Ultraviolet Rays; Injury
  • +3 more
  • Ultraviolet radiation
  • Copenhagen NV, Denmark
    Bispebjerg Hospital, Department of Dermatology
Jul 19, 2022

Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • RP-3500 in combination with Olaparib
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 23, 2022

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)

Active, not recruiting
  • Castration Resistant Prostatic Cancer
  • Metastatic Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
May 17, 2022

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Natural History Study for DNA Repair Disorders

Not yet recruiting
  • DNA Repair Disorder
  • +3 more
  • Interval History
  • +4 more
  • Minneapolis, Minnesota
    University of Minnesota- Twin Cities
Aug 8, 2022

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,

Recruiting
  • MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
  • Kashiwa, Chiba, Japan
    Novartis Investigative Site
May 2, 2023

BRCA and DNA Damage Repair Genes in Blood Samples of Chinese

Recruiting
  • Pancreatic Cancer
  • Observation
  • Shanghai, Shanghai, China
    RenJiH
Nov 17, 2021

Endometrial Adenocarcinoma, Endometrial Carcinoma, Lynch Syndrome Trial in United States (Genetic Counseling, Genetic Testing,

Active, not recruiting
  • Endometrial Adenocarcinoma
  • +3 more
  • Genetic Counseling
  • +3 more
  • Akron, Ohio
  • +8 more
Dec 2, 2022

Tumor Molecular Profiling in Patients With Prostate Cancer

Completed
  • Prostate Cancer
  • Metastatic Prostate Adenocarcinoma
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Oct 17, 2022

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Cancers With DNA Repair-Deficiency Trial in Germany (Olaparib, Physician's choice, Trabectedin)

Recruiting
  • Cancers With DNA Repair-Deficiency
  • Dresden, Germany
  • +8 more
Jan 12, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Sleep Quality, DNA Damage Repair Deficiency, Oxidative Stress Trial (Melatonin, Placebo)

Unknown status
  • Sleep Quality
  • +2 more
  • Melatonin
  • Placebo
  • (no location specified)
May 8, 2019

DDR Gene Mutation, Metastatic Solid Tumor Trial in Seoul (Nivolumab)

Unknown status
  • DDR Gene Mutation
  • Metastatic Solid Tumor
  • Seoul, Chongro-ku, Korea, Republic of
  • +1 more
Feb 16, 2021

Sarcoma,Soft Tissue, Sarcoma Uterus Trial in United States (Niraparib)

Recruiting
  • Sarcoma,Soft Tissue
  • Sarcoma Uterus
  • Basking Ridge, New Jersey
  • +6 more
Aug 23, 2022